The hippocampus associated GABAergic neural network impairment in early-stage of Alzheimer's disease

[1]  P. Somogyi,et al.  Spread of pathological human Tau from neurons to oligodendrocytes and loss of high-firing pyramidal neurons in aging mice , 2022, bioRxiv.

[2]  Yi Liu,et al.  Prefrontal parvalbumin interneurons deficits mediate early emotional dysfunction in Alzheimer’s disease , 2022, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[3]  A. Schousboe,et al.  Astrocyte energy and neurotransmitter metabolism in Alzheimer’s disease: Integration of the glutamate/GABA-glutamine cycle , 2022, Progress in Neurobiology.

[4]  Natalie Matosin,et al.  Neuronal hyperexcitability in Alzheimer’s disease: what are the drivers behind this aberrant phenotype? , 2022, Translational Psychiatry.

[5]  M. Korte,et al.  APPsα Rescues Tau-Induced Synaptic Pathology , 2022, Journal of Neuroscience.

[6]  J. McLaurin,et al.  Parvalbumin neuroplasticity compensates for somatostatin impairment, maintaining cognitive function in Alzheimer’s disease , 2022, Translational neurodegeneration.

[7]  Li I. Zhang,et al.  A bottom-up reward pathway mediated by somatostatin neurons in the medial septum complex underlying appetitive learning , 2022, Nature Communications.

[8]  Afia B Ali,et al.  Alzheimer’s Disease Enhanced Tonic Inhibition is Correlated With Upregulated Astrocyte GABA Transporter-3/4 in a Knock-In APP Mouse Model , 2022, Frontiers in Pharmacology.

[9]  He Cui,et al.  A hippocampus dependent neural circuit loop underlying the generation of auditory mismatch negativity , 2022, Neuropharmacology.

[10]  V. Sohal,et al.  Top-down control of hippocampal signal-to-noise by prefrontal long-range inhibition , 2021, Cell.

[11]  K. Vossel,et al.  Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial. , 2021, JAMA neurology.

[12]  W. Johnson,et al.  Wolframin-1–expressing neurons in the entorhinal cortex propagate tau to CA1 neurons and impair hippocampal memory in mice , 2021, Science Translational Medicine.

[13]  E. Frangou,et al.  An Investigation of Levetiracetam in Alzheimer’s Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study , 2021, Trials.

[14]  Yousheng Shu,et al.  Prefrontal GABAergic Interneurons Gate Long-Range Afferents to Regulate Prefrontal Cortex-Associated Complex Behaviors , 2021, Frontiers in Neural Circuits.

[15]  C. J. Lee,et al.  Differential Proximity of Perisynaptic Astrocytic Best1 at the Excitatory and Inhibitory Tripartite Synapses in APP/PS1 and MAOB-KO Mice Revealed by Lattice Structured Illumination Microscopy , 2021, Experimental neurobiology.

[16]  W. Wang,et al.  Reversible GABAergic dysfunction involved in hippocampal hyperactivity predicts early-stage Alzheimer disease in a mouse model , 2021, Alzheimer's research & therapy.

[17]  N. Hájos.  Interneuron Types and Their Circuits in the Basolateral Amygdala , 2021, Frontiers in Neural Circuits.

[18]  R. Xu,et al.  Predict Alzheimer’s disease using hippocampus MRI data: a lightweight 3D deep convolutional network model with visual and global shape representations , 2021, Alzheimer's Research & Therapy.

[19]  Ane Charlotte Christensen,et al.  Optogenetic pacing of medial septum parvalbumin-positive cells disrupts temporal but not spatial firing in grid cells , 2021, Science Advances.

[20]  H. Monyer,et al.  Two septal-entorhinal GABAergic projections differentially control coding properties of spatially tuned neurons in the medial entorhinal cortex. , 2021, Cell Reports.

[21]  L. Ouyang,et al.  Participation of Amyloid and Tau Protein in Post-Ischemic Neurodegeneration of the Hippocampus of a Nature Identical to Alzheimer’s Disease , 2021, International journal of molecular sciences.

[22]  A. Webb,et al.  Adult Hippocampal Neurogenesis in Aging and Alzheimer's Disease , 2021, Stem cell reports.

[23]  Teal S Eich,et al.  GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer’s disease , 2021, Seminars in cell & developmental biology.

[24]  Rui-Xi Li,et al.  Differential efferent projections of GABAergic neurons in the basolateral and central nucleus of amygdala in mice , 2021, Neuroscience Letters.

[25]  H. Tanila,et al.  Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer's disease , 2020, Neurobiology of Disease.

[26]  J. DeFelipe,et al.  3D Analysis of the Synaptic Organization in the Entorhinal Cortex in Alzheimer’s Disease , 2020, eNeuro.

[27]  Csaba Varga,et al.  Somatostatin expressing GABAergic interneurons in the medial entorhinal cortex preferentially inhibit layerIII-V pyramidal cells , 2020, Communications biology.

[28]  R. Faull,et al.  Impaired Expression of GABA Signaling Components in the Alzheimer’s Disease Middle Temporal Gyrus , 2020, International journal of molecular sciences.

[29]  Ki Duk Park,et al.  Astrocytes Control Sensory Acuity via Tonic Inhibition in the Thalamus , 2020, Neuron.

[30]  H. Monyer,et al.  Diversity and function of corticopetal and corticofugal GABAergic projection neurons , 2020, Nature Reviews Neuroscience.

[31]  Kei M. Igarashi,et al.  Disrupted Place Cell Remapping and Impaired Grid Cells in a Knockin Model of Alzheimer's Disease , 2020, Neuron.

[32]  J. Storm-Mathisen,et al.  Slc38a1 Conveys Astroglia-Derived Glutamine into GABAergic Interneurons for Neurotransmitter GABA Synthesis , 2020, Cells.

[33]  Yilan Xu,et al.  GABAergic Inhibitory Interneuron Deficits in Alzheimer’s Disease: Implications for Treatment , 2020, Frontiers in Neuroscience.

[34]  Yong Shen,et al.  GABAergic dysfunction in excitatory and inhibitory (E/I) imbalance drives the pathogenesis of Alzheimer's disease , 2020, Alzheimer's & dementia : the journal of the Alzheimer's Association.

[35]  F. Fornai,et al.  Epilepsy and Alzheimer’s Disease: Potential mechanisms for an association , 2020, Brain Research Bulletin.

[36]  Alexey Semyanov,et al.  Tonic GABAA Conductance Favors Spike-Timing-Dependent over Theta-Burst-Induced Long-Term Potentiation in the Hippocampus , 2020, The Journal of Neuroscience.

[37]  Ming-Rong Zhang,et al.  Selective Disruption of Inhibitory Synapses Leading to Neuronal Hyperexcitability at an Early Stage of Tau Pathogenesis in a Mouse Model , 2020, The Journal of Neuroscience.

[38]  N. Neff,et al.  Molecular characterization of selectively vulnerable neurons in Alzheimer’s Disease , 2020, Nature Neuroscience.

[39]  R. Shigemoto,et al.  Density of GABAB Receptors Is Reduced in Granule Cells of the Hippocampus in a Mouse Model of Alzheimer’s Disease , 2020, International journal of molecular sciences.

[40]  E. Beghi,et al.  Epilepsy, antiepileptic drugs and dementia. , 2020, Current opinion in neurology.

[41]  H. Gong,et al.  Ventral Hippocampal-Prefrontal Interaction Affects Social Behavior via Parvalbumin Positive Neurons in the Medial Prefrontal Cortex , 2020, iScience.

[42]  Thomas Hainmueller,et al.  Dentate gyrus circuits for encoding, retrieval and discrimination of episodic memories , 2020, Nature Reviews Neuroscience.

[43]  Ki Duk Park,et al.  Aberrant Tonic Inhibition of Dopaminergic Neuronal Activity Causes Motor Symptoms in Animal Models of Parkinson’s Disease , 2020, Current Biology.

[44]  S. Duan,et al.  Direct Septum-Hippocampus Cholinergic Circuit Attenuates Seizure Through Driving Somatostatin Inhibition , 2019, Biological Psychiatry.

[45]  M. Mattson.  Involvement of GABAergic interneuron dysfunction and neuronal network hyperexcitability in Alzheimer's disease: Amelioration by metabolic switching. , 2020, International review of neurobiology.

[46]  Dong Woon Kim,et al.  Bestrophin1‐mediated tonic GABA release from reactive astrocytes prevents the development of seizure‐prone network in kainate‐injected hippocampi , 2019, Glia.

[47]  R. Shigemoto,et al.  Reduction in the neuronal surface of post and presynaptic GABAB receptors in the hippocampus in a mouse model of Alzheimer's disease , 2019, Brain pathology.

[48]  P. Scheltens,et al.  Early restoration of parvalbumin interneuron activity prevents memory loss and network hyperexcitability in a mouse model of Alzheimer’s disease , 2019, Molecular Psychiatry.

[49]  M. Moon,et al.  Topographical Visualization of the Reciprocal Projection between the Medial Septum and the Hippocampus in the 5XFAD Mouse Model of Alzheimer’s Disease , 2019, International journal of molecular sciences.

[50]  N. Sui,et al.  Parvalbumin interneuron in the ventral hippocampus functions as a discriminator in social memory , 2019, Proceedings of the National Academy of Sciences.

[51]  Qingming Luo,et al.  A whole-brain map of long-range inputs to GABAergic interneurons in the mouse medial prefrontal cortex , 2019, Nature Neuroscience.

[52]  Francisco J Luongo,et al.  VIP Interneurons Contribute to Avoidance Behavior by Regulating Information Flow across Hippocampal-Prefrontal Networks , 2019, Neuron.

[53]  Thomas J. McHugh,et al.  Gamma Entrainment Binds Higher-Order Brain Regions and Offers Neuroprotection , 2019, Neuron.

[54]  Jialin C. Zheng,et al.  Reactive Astrocytes in Neurodegenerative Diseases , 2019, Aging and disease.

[55]  E. Zimmer,et al.  The astrocyte biochemistry. , 2019, Seminars in cell & developmental biology.

[56]  O. Garaschuk,et al.  GABAergic astrocytes in Alzheimer’s disease , 2019, Aging.

[57]  C. Blanco-Centurion,et al.  Amygdala GABA Neurons Project To vlPAG And mPFC , 2019, IBRO reports.

[58]  Ashwini M. Londhe,et al.  Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer’s disease , 2019, Science Advances.

[59]  C. Murphy.  Olfactory and other sensory impairments in Alzheimer disease , 2018, Nature Reviews Neurology.

[60]  J. Gordon,et al.  Somatostatin Interneurons Facilitate Hippocampal-Prefrontal Synchrony and Prefrontal Spatial Encoding , 2018, Neuron.

[61]  S. Siegelbaum,et al.  A hippocampal circuit linking dorsal CA2 to ventral CA1 critical for social memory dynamics , 2018, Nature Communications.

[62]  Oscar Marín,et al.  Development and Functional Diversification of Cortical Interneurons , 2018, Neuron.

[63]  T. Yamamoto,et al.  Altered expression of glutamate transporter‐1 and water channel protein aquaporin‐4 in human temporal cortex with Alzheimer's disease , 2018, Neuropathology and applied neurobiology.

[64]  R. Faull,et al.  Gamma-aminobutyric acid A receptors in Alzheimer's disease: highly localized remodeling of a complex and diverse signaling pathway , 2018, Neural regeneration research.

[65]  R. Marek,et al.  Author Correction: Hippocampus-driven feed-forward inhibition of the prefrontal cortex mediates relapse of extinguished fear , 2018, Nature Neuroscience.

[66]  Benedikt Zott,et al.  What Happens with the Circuit in Alzheimer's Disease in Mice and Humans? , 2018, Annual review of neuroscience.

[67]  Taylor W. Schmitz,et al.  Longitudinal Alzheimer's Degeneration Reflects the Spatial Topography of Cholinergic Basal Forebrain Projections. , 2018, Cell reports.

[68]  Adam G. Carter,et al.  Ventral Hippocampal Inputs Preferentially Drive Corticocortical Neurons in the Infralimbic Prefrontal Cortex , 2018, The Journal of Neuroscience.

[69]  R. Faull,et al.  GABAA receptor subunit expression changes in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus , 2018, Journal of neurochemistry.

[70]  M. Álvarez-Dolado,et al.  Nav1.1-Overexpressing Interneuron Transplants Restore Brain Rhythms and Cognition in a Mouse Model of Alzheimer’s Disease , 2018, Neuron.

[71]  A. Losonczy,et al.  CA1 pyramidal cell diversity enabling parallel information processing in the hippocampus , 2018, Nature Neuroscience.

[72]  Paolo Bazzigaluppi,et al.  Early‐stage attenuation of phase‐amplitude coupling in the hippocampus and medial prefrontal cortex in a transgenic rat model of Alzheimer's disease , 2018, Journal of neurochemistry.

[73]  I. Mook‐Jung,et al.  Visualization of Altered Hippocampal Connectivity in an Animal Model of Alzheimer’s Disease , 2018, Molecular Neurobiology.

[74]  J. Yakel,et al.  Septal cholinergic neurons gate hippocampal output to entorhinal cortex via oriens lacunosum moleculare interneurons , 2018, Proceedings of the National Academy of Sciences.

[75]  O. Garaschuk,et al.  A bell-shaped dependence between amyloidosis and GABA accumulation in astrocytes in a mouse model of Alzheimer's disease , 2018, Neurobiology of Aging.

[76]  M. Moser,et al.  Entorhinal fast-spiking speed cells project to the hippocampus , 2018, Proceedings of the National Academy of Sciences.

[77]  Bernardo Rudy,et al.  Diversity and Connectivity of Layer 5 Somatostatin-Expressing Interneurons in the Mouse Barrel Cortex , 2018, The Journal of Neuroscience.

[78]  J. Wu,et al.  A novel mechanism of memory loss in Alzheimer’s disease mice via the degeneration of entorhinal–CA1 synapses , 2016, Molecular Psychiatry.

[79]  M. Nedergaard,et al.  Physiology of Astroglia. , 2018, Physiological reviews.

[80]  C. Allen,et al.  GABA transporters regulate tonic and synaptic GABAA receptor-mediated currents in the suprachiasmatic nucleus neurons. , 2017, Journal of neurophysiology.

[81]  Geoffrey M. Barrett,et al.  Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer’s disease-like pathology , 2017, Nature Communications.

[82]  K. Deisseroth,et al.  Long-Range GABAergic Inputs Regulate Neural Stem Cell Quiescence and Control Adult Hippocampal Neurogenesis. , 2017, Cell stem cell.

[83]  Michael Hornberger,et al.  Factors underlying cognitive decline in old age and Alzheimer’s disease: the role of the hippocampus , 2017, Reviews in the neurosciences.

[84]  M. Moser,et al.  Parvalbumin and Somatostatin Interneurons Control Different Space-Coding Networks in the Medial Entorhinal Cortex , 2017, Cell.

[85]  Jason C. Wester,et al.  Hippocampal GABAergic Inhibitory Interneurons. , 2017, Physiological reviews.

[86]  J. Molinuevo,et al.  Alzheimer’s disease prevention: from risk factors to early intervention , 2017, Alzheimer's Research & Therapy.

[87]  H. Eichenbaum.  On the Integration of Space, Time, and Memory , 2017, Neuron.

[88]  R. Faull,et al.  Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease , 2017, International journal of molecular sciences.

[89]  S. Oh,et al.  Distribution and Function of the Bestrophin-1 (Best1) Channel in the Brain , 2017, Experimental neurobiology.

[90]  R. Faull,et al.  Impaired expression of GABA transporters in the human Alzheimer’s disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus , 2017, Neuroscience.

[91]  S. Gauthier,et al.  Monoamine oxidase B inhibitor, selegiline, reduces 18F-THK5351 uptake in the human brain , 2017, Alzheimer's Research & Therapy.

[92]  Ki Duk Park,et al.  Indole-Substituted Benzothiazoles and Benzoxazoles as Selective and Reversible MAO-B Inhibitors for Treatment of Parkinson's Disease. , 2017, ACS chemical neuroscience.

[93]  R. Goutagny,et al.  Differential contribution of APP metabolites to early cognitive deficits in a TgCRND8 mouse model of Alzheimer’s disease , 2017, Science Advances.

[94]  M. Pascual,et al.  The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy , 2017, Neurobiology of Aging.

[95]  Bo Li,et al.  Prefrontal Cortical GABAergic Dysfunction Contributes to Aberrant UP-State Duration in APP Knockout Mice , 2016, Cerebral cortex.

[96]  Heidi E Kirsch,et al.  Incidence and impact of subclinical epileptiform activity in Alzheimer's disease , 2016, Annals of neurology.

[97]  Dmitri A Rusakov,et al.  Astrocytic GABA transporter activity modulates excitatory neurotransmission , 2016, Nature Communications.

[98]  T. Murphy,et al.  Mapping synaptic glutamate transporter dysfunction in vivo to regions surrounding Aβ plaques by iGluSnFR two-photon imaging , 2016, Nature Communications.

[99]  L. Mucke,et al.  Network abnormalities and interneuron dysfunction in Alzheimer disease , 2016, Nature Reviews Neuroscience.

[100]  L. Tsai,et al.  The road to restoring neural circuits for the treatment of Alzheimer's disease , 2016, Nature.

[101]  N. Sousa,et al.  Patterns of Theta Activity in Limbic Anxiety Circuit Preceding Exploratory Behavior in Approach-Avoidance Conflict , 2016, Front. Behav. Neurosci..

[102]  Michael Lagler,et al.  Divisions of Identified Parvalbumin-Expressing Basket Cells during Working Memory-Guided Decision Making , 2016, Neuron.

[103]  E. Hol,et al.  Astrogliosis: An integral player in the pathogenesis of Alzheimer's disease , 2016, Progress in Neurobiology.

[104]  Gary H Wynn,et al.  The basolateral amygdala γ‐aminobutyric acidergic system in health and disease , 2016, Journal of neuroscience research.

[105]  Masahiko Watanabe,et al.  Medial septal GABAergic projection neurons promote object exploration behavior and type 2 theta rhythm , 2016, Proceedings of the National Academy of Sciences.

[106]  F. Helmchen,et al.  Spatially segregated feedforward and feedback neurons support differential odor processing in the lateral entorhinal cortex , 2016, Nature Neuroscience.

[107]  Antoine Adamantidis,et al.  Causal evidence for the role of REM sleep theta rhythm in contextual memory consolidation , 2016, Science.

[108]  G. Feng,et al.  Optogenetic dissection of ictal propagation in the hippocampal–entorhinal cortex structures , 2016, Nature Communications.

[109]  David M. Smith,et al.  Placing memories in context: Hippocampal representations promote retrieval of appropriate memories , 2016, Hippocampus.

[110]  M. Seeck,et al.  From here to epilepsy: the risk of seizure in patients with Alzheimer's disease. , 2016, Epileptic disorders : international epilepsy journal with videotape.

[111]  J. Gordon,et al.  Direct Ventral Hippocampal-Prefrontal Input Is Required for Anxiety-Related Neural Activity and Behavior , 2016, Neuron.

[112]  A. Martínez-Marcos,et al.  Interneurons in the human olfactory system in Alzheimer's disease , 2016, Experimental Neurology.

[113]  R. Pascual-Marqui,et al.  Functional connectivity assessed by resting state EEG correlates with cognitive decline of Alzheimer’s disease – An eLORETA study , 2016, Clinical Neurophysiology.

[114]  Shaomin Li,et al.  Soluble Aβ oligomers impair hippocampal LTP by disrupting glutamatergic/GABAergic balance , 2016, Neurobiology of Disease.

[115]  Attila Losonczy,et al.  Gating of hippocampal activity, plasticity, and memory by entorhinal cortex long-range inhibition , 2016, Science.

[116]  Hannah Monyer,et al.  Local and Distant Input Controlling Excitation in Layer II of the Medial Entorhinal Cortex , 2016, Neuron.

[117]  Jean-Christophe Cassel,et al.  Precocious Alterations of Brain Oscillatory Activity in Alzheimer’s Disease: A Window of Opportunity for Early Diagnosis and Treatment , 2015, Front. Cell. Neurosci..

[118]  S. Leurgans,et al.  Loss of Munc18-1 long splice variant in GABAergic terminals is associated with cognitive decline and increased risk of dementia in a community sample , 2015, Molecular Neurodegeneration.

[119]  Peter Somogyi,et al.  Synaptic Targets of Medial Septal Projections in the Hippocampus and Extrahippocampal Cortices of the Mouse , 2015, The Journal of Neuroscience.

[120]  Hans Förstl,et al.  Decreased amyloid-β and increased neuronal hyperactivity by immunotherapy in Alzheimer's models , 2015, Nature Neuroscience.

[121]  Stephen Maren,et al.  The Role of the Medial Prefrontal Cortex in the Conditioning and Extinction of Fear , 2015, Front. Behav. Neurosci..

[122]  O. Stork,et al.  Identification and Characterization of GABAergic Projection Neurons from Ventral Hippocampus to Amygdala , 2015, Brain sciences.

[123]  J. Bizon,et al.  Molecular aspects of age-related cognitive decline: the role of GABA signaling. , 2015, Trends in molecular medicine.

[124]  R. Bullock,et al.  Incidence of stroke and seizure in Alzheimer's disease dementia. , 2015, Age and ageing.

[125]  Fei Gao,et al.  Decreased γ‐aminobutyric acid levels in the parietal region of patients with Alzheimer's disease , 2015, Journal of magnetic resonance imaging : JMRI.

[126]  V. Zaric,et al.  GABAergic somatostatin-immunoreactive neurons in the amygdala project to the entorhinal cortex , 2015, Neuroscience.

[127]  Y. Bae,et al.  Channel-mediated astrocytic glutamate modulates hippocampal synaptic plasticity by activating postsynaptic NMDA receptors , 2015, Molecular Brain.

[128]  E. Hol,et al.  Glial fibrillary acidic protein (GFAP) and the astrocyte intermediate filament system in diseases of the central nervous system. , 2015, Current opinion in cell biology.

[129]  E. Rolls,et al.  A computational theory of hippocampal function, and tests of the theory: New developments , 2015, Neuroscience & Biobehavioral Reviews.

[130]  B. L. de Groot,et al.  Mechanisms of Anion Conduction by Coupled Glutamate Transporters , 2015, Cell.

[131]  K. Tye,et al.  From circuits to behaviour in the amygdala , 2015, Nature.

[132]  A. Martínez-Marcos,et al.  Interneurons, tau and amyloid-β in the piriform cortex in Alzheimer’s disease , 2015, Brain Structure and Function.

[133]  A. Schousboe,et al.  The Glutamine–Glutamate/GABA Cycle: Function, Regional Differences in Glutamate and GABA Production and Effects of Interference with GABA Metabolism , 2015, Neurochemical Research.

[134]  Antonio Candela,et al.  GABAergic Projections from the Medial Septum Selectively Inhibit Interneurons in the Medial Entorhinal Cortex , 2014, The Journal of Neuroscience.

[135]  Shao Li,et al.  Lamotrigine attenuates deficits in synaptic plasticity and accumulation of amyloid plaques in APP/PS1 transgenic mice , 2014, Neurobiology of Aging.

[136]  Y. Bae,et al.  Glial GABA, synthesized by monoamine oxidase B, mediates tonic inhibition , 2014, The Journal of physiology.

[137]  J. Delgado-García,et al.  The GABAergic septohippocampal pathway is directly involved in internal processes related to operant reward learning. , 2014, Cerebral cortex.

[138]  Yong Jeong,et al.  GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease , 2014, Nature Medicine.

[139]  Javier Yajeya,et al.  GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer’s disease , 2014, Front. Cell. Neurosci..

[140]  M. Gearing,et al.  Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzhiemer’s disease model , 2014, Nature Communications.

[141]  J. McLaurin,et al.  α-Melanocyte Stimulating Hormone Prevents GABAergic Neuronal Loss and Improves Cognitive Function in Alzheimer's Disease , 2014, The Journal of Neuroscience.

[142]  J. Gigg,et al.  Increased Hippocampal Excitability in the 3xTgAD Mouse Model for Alzheimer's Disease In Vivo , 2014, PloS one.

[143]  B. Setlow,et al.  Prefrontal Cortical GABAergic Dysfunction Contributes to Age-Related Working Memory Impairment , 2014, The Journal of Neuroscience.

[144]  J. Middeldorp,et al.  Glial fibrillary acidic protein isoform expression in plaque related astrogliosis in Alzheimer's disease , 2014, Neurobiology of Aging.

[145]  S. Siegelbaum,et al.  The hippocampal CA2 region is essential for social memory , 2014, Nature.

[146]  S. Tonegawa,et al.  Island Cells Control Temporal Association Memory , 2014, Science.

[147]  O. Garaschuk,et al.  Network-wide dysregulation of calcium homeostasis in Alzheimer’s disease , 2014, Cell and Tissue Research.

[148]  J. Maguire,et al.  The impact of tonic GABAA receptor-mediated inhibition on neuronal excitability varies across brain region and cell type , 2014, Front. Neural Circuits.

[149]  G. Fishell,et al.  Interneuron cell types are fit to function , 2014, Nature.

[150]  H. Eichenbaum,et al.  Distinct Hippocampal Time Cell Sequences Represent Odor Memories in Immobilized Rats , 2013, The Journal of Neuroscience.

[151]  Heidi E Kirsch,et al.  Seizures and epileptiform activity in the early stages of Alzheimer disease. , 2013, JAMA neurology.

[152]  A. Martínez-Marcos,et al.  Interneurons and Beta‐Amyloid in the Olfactory Bulb, Anterior Olfactory Nucleus and Olfactory Tubercle in APPxPS1 Transgenic Mice Model of Alzheimer's Disease , 2013, Anatomical record.

[153]  Helen Wong,et al.  Tau pathology induces loss of GABAergic interneurons leading to altered synaptic plasticity and behavioral impairments , 2013, Acta neuropathologica communications.

[154]  M. Schuerch,et al.  Seizures in patients with Alzheimer’s disease or vascular dementia: A population‐based nested case–control analysis , 2013, Epilepsia.

[155]  Alexey Semyanov,et al.  A functional role for both γ-aminobutyric acid (GABA) transporter-1 and GABA transporter-3 in the modulation of extracellular GABA and GABAergic tonic conductances in the rat hippocampus , 2013, The Journal of physiology.

[156]  Shelly C. Lu.  Glutathione synthesis. , 2013, Biochimica et biophysica acta.

[157]  M. Zarrindast,et al.  Septo-Hippocampo-Septal Loop and Memory Formation , 2013, Basic and clinical neuroscience.

[158]  J. Delgado-García,et al.  Accelerated aging of the GABAergic septohippocampal pathway and decreased hippocampal rhythms in a mouse model of Alzheimer's disease , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[159]  M. Capogna,et al.  Neurogliaform cells of amygdala: a source of slow phasic inhibition in the basolateral complex , 2012, The Journal of physiology.

[160]  Sachin S. Deshmukh,et al.  Perirhinal cortex represents nonspatial, but not spatial, information in rats foraging in the presence of objects: Comparison with lateral entorhinal cortex , 2012, Hippocampus.

[161]  J. Kinney,et al.  Deficits in emotional learning and memory in an animal model of schizophrenia , 2012, Behavioural Brain Research.

[162]  M. Frotscher,et al.  Selective degeneration of septal and hippocampal GABAergic neurons in a mouse model of amyloidosis and tauopathy , 2012, Neurobiology of Disease.

[163]  R. McCarley,et al.  Control of sleep and wakefulness. , 2012, Physiological reviews.

[164]  Gerald J. Sun,et al.  Neuronal circuitry mechanism regulating adult quiescent neural stem cell fate decision , 2012, Nature.

[165]  Marco Capogna,et al.  Cell-Type-Specific Recruitment of Amygdala Interneurons to Hippocampal Theta Rhythm and Noxious Stimuli In Vivo , 2012, Neuron.

[166]  R. Miledi,et al.  Loss of functional GABAA receptors in the Alzheimer diseased brain , 2012, Proceedings of the National Academy of Sciences.

[167]  Edward O. Mann,et al.  Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model , 2012, Cell.

[168]  M. Whittington,et al.  Long-Range–Projecting GABAergic Neurons Modulate Inhibition in Hippocampus and Entorhinal Cortex , 2012, Science.

[169]  A. Losonczy,et al.  Regulation of neuronal input transformations by tunable dendritic inhibition , 2012, Nature Neuroscience.

[170]  Oliver Wirths,et al.  Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease , 2012, Neurobiology of Aging.

[171]  M. Palkovits,et al.  Astrocytes convert network excitation to tonic inhibition of neurons , 2012, BMC Biology.

[172]  Daesoo Kim,et al.  The amount of astrocytic GABA positively correlates with the degree of tonic inhibition in hippocampal CA1 and cerebellum , 2011, Molecular Brain.

[173]  H. Eichenbaum,et al.  Hippocampal “Time Cells” Bridge the Gap in Memory for Discontiguous Events , 2011, Neuron.

[174]  A. Blokland,et al.  Acetylcholine and attention , 2011, Behavioural Brain Research.

[175]  J. Shin,et al.  The interrelationship between movement and cognition: Theta rhythm and the P300 event‐related potential , 2011, Hippocampus.

[176]  S. Jinno.  Topographic differences in adult neurogenesis in the mouse hippocampus: A stereology‐based study using endogenous markers , 2011, Hippocampus.

[177]  R. Vandenberg,et al.  Glutamate transporter variants reduce glutamate uptake in Alzheimer's disease , 2011, Neurobiology of Aging.

[178]  J. Huguenard,et al.  Astrocytes as Gatekeepers of GABAB Receptor Function , 2010, The Journal of Neuroscience.

[179]  Hee-Sup Shin,et al.  Channel-Mediated Tonic GABA Release from Glia , 2010, Science.

[180]  M. O’Banion,et al.  Neuroinflammatory processes in Alzheimer’s disease , 2010, Journal of Neural Transmission.

[181]  R. Sperling,et al.  Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline , 2010, Neurology.

[182]  R. Insausti,et al.  Somatostatin, tau, and β-amyloid within the anterior olfactory nucleus in Alzheimer disease , 2010, Experimental Neurology.

[183]  I. Soltesz,et al.  Target-selective GABAergic control of entorhinal cortex output , 2010, Nature Neuroscience.

[184]  F. LaFerla,et al.  Intraneuronal β-Amyloid Accumulation in the Amygdala Enhances Fear and Anxiety in Alzheimer's Disease Transgenic Mice , 2010, Biological Psychiatry.

[185]  P. Hof,et al.  Hippocampal interneuron loss in an APP/PS1 double mutant mouse and in Alzheimer’s disease , 2010, Brain Structure and Function.

[186]  Gustavo Puras,et al.  Medial septal β-amyloid 1-40 injections alter septo-hippocampal anatomy and function , 2010, Neurobiology of Aging.

[187]  A. Buffo,et al.  Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential. , 2010, Biochemical pharmacology.

[188]  Hong-wei Dong,et al.  Are the Dorsal and Ventral Hippocampus Functionally Distinct Structures? , 2010, Neuron.

[189]  R. Mahley,et al.  GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice. , 2009, Cell stem cell.

[190]  Isidro Ferrer,et al.  Diminished Perisomatic GABAergic Terminals on Cortical Neurons Adjacent to Amyloid Plaques , 2009, Front. Neuroanat..

[191]  M. Palkovits,et al.  Glutamate Uptake Triggers Transporter-Mediated GABA Release from Astrocytes , 2009, PloS one.

[192]  Z. Borhegyi,et al.  GABAergic Neurons of the Medial Septum Lead the Hippocampal Network during Theta Activity , 2009, The Journal of Neuroscience.

[193]  R. Petersen,et al.  Recurrent seizures in patients with dementia: Frequency, seizure types, and treatment outcome , 2009, Epilepsy & Behavior.

[194]  Arthur Konnerth,et al.  Clusters of Hyperactive Neurons Near Amyloid Plaques in a Mouse Model of Alzheimer's Disease , 2008, Science.

[195]  Anatol C. Kreitzer,et al.  Aberrant Excitatory Neuronal Activity and Compensatory Remodeling of Inhibitory Hippocampal Circuits in Mouse Models of Alzheimer's Disease , 2007, Neuron.

[196]  P Riederer,et al.  Alterations in expression of glutamatergic transporters and receptors in sporadic Alzheimer's disease. , 2007, Journal of Alzheimer's disease : JAD.

[197]  J. F. López-Téllez,et al.  Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1×APP transgenic model of Alzheimer's disease , 2006, Neurobiology of Aging.

[198]  M. Ohno,et al.  Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation , 2006, The Journal of Neuroscience.

[199]  G. Kinney.  GAT-3 transporters regulate inhibition in the neocortex. , 2005, Journal of neurophysiology.

[200]  Zhen Yan,et al.  Phospho-dependent binding of the clathrin AP2 adaptor complex to GABAA receptors regulates the efficacy of inhibitory synaptic transmission. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[201]  J. Knierim,et al.  Major Dissociation Between Medial and Lateral Entorhinal Input to Dorsal Hippocampus , 2005, Science.

[202]  Jacob Raber,et al.  Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[203]  T. Wyss-Coray,et al.  Adult mouse astrocytes degrade amyloid-β in vitro and in situ , 2003, Nature Medicine.

[204]  R. Swanson,et al.  Astrocyte glutamate transport: Review of properties, regulation, and physiological functions , 2000, Glia.

[205]  Mark S. Cohen,et al.  Patterns of brain activation in people at risk for Alzheimer's disease. , 2000, The New England journal of medicine.

[206]  S. Duan,et al.  Glutamate Induces Rapid Upregulation of Astrocyte Glutamate Transport and Cell-Surface Expression of GLAST , 1999, The Journal of Neuroscience.

[207]  H. Soininen,et al.  Subfield- and layer-specific changes in parvalbumin, calretinin and calbindin-D28k immunoreactivity in the entorhinal cortex in Alzheimer's disease , 1999, Neuroscience.

[208]  A. Delacourte,et al.  Loss of somatostatin-like immunoreactivity in the frontal cortex of Alzheimer patients carrying the apolipoprotein epsilon 4 allele , 1998, Neuroscience Letters.

[209]  T. Yagi,et al.  Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[210]  T. Freund,et al.  Disinhibition of rat hippocampal pyramidal cells by GABAergic afferents from the septum. , 1997, The Journal of physiology.

[211]  T. Yagi,et al.  Mice lacking the 65 kDa isoform of glutamic acid decarboxylase (GAD65) maintain normal levels of GAD67 and GABA in their brains but are susceptible to seizures. , 1996, Biochemical and biophysical research communications.

[212]  A. Schousboe,et al.  Utilization of glutamine and of TCA cycle constituents as precursors for transmitter glutamate and GABA. , 1993, Developmental neuroscience.

[213]  B. E. Jones,et al.  Paradoxical sleep and its chemical/structural substrates in the brain , 1991, Neuroscience.

[214]  Leif Hertz,et al.  Metabolic Fate of 14C‐Labeled Glutamate in Astrocytes in Primary Cultures , 1982, Journal of neurochemistry.